Trial Profile
Effects of long-term natalizumab treatment on cell-bound natalizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- 15 Dec 2015 New trial record